CLPT ClearPoint Neuro, Inc.
ClearPoint Neuro, Inc. (CLPT) is expected to report earnings on November 2, 2026, after the market close. The consensus earnings estimate is a loss of $0.31 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +2.9% since its last earnings release on August 3, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About ClearPoint Neuro, Inc.
ClearPoint Neuro’s mission is to improve and restore quality of life to patients and their families by enabling therapies for the most complex neurological disorders with pinpoint accuracy.
Sector
Healthcare
Industry
Medical Instruments/Supply